Transcatheter Mitral Valve Repair and Replacement (TMVR) Market Size, Share, Growth, and Industry Analysis by Type (Repair & Replacement), By Application (Hospitals, Ambulatory Surgical Centers & Diagnostic Centers), Regional Insights and Forecast From 2026 To 2035

• 

  Download Free Sample to learn more about this report

TRANSCATHETER MITRAL VALVE REPAIR AND REPLACEMENT (TMVR) MARKET OVERVIEW

The global transcatheter mitral valve repair and replacement (tmvr) market size is estimated at USD 3.86 Billion in 2026 and is expected to reach USD 34.27 Billion by 2035 at a CAGR of 27.2% during the forecast from 2026 to 2035.

A cutting-edge medical treatment called transcatheter mitral valve repair and replacement (TMVR) is used to address disorders that damage the heart's mitral valve. One of the four valves in the heart, the mitral valve ensures that blood flows through the heart in the right direction. A number of cardiac issues, such as mitral regurgitation (blood spilling backward into the left atrium) or mitral stenosis (narrowing of the valve opening), can result from this valve becoming ill or malfunctioning. The mitral valve can be repaired or replaced via TMVR, which requires no open-heart surgery.

It entails the use of specialized catheters and devices that are led to the heart through blood arteries, frequently the femoral artery in the leg. Patients are thoroughly evaluated prior to TMVR in order to check the health of the mitral valve and determine whether they are good candidates for the treatment. This may include echocardiography, cardiac MRI, or CT scans. Patients who are at high risk for open cardiac surgery or who are not good candidates for conventional surgical repair or replacement are frequently given consideration for TMVR.

KEY FINDINGS

COVID-19 IMPACT

Industry Shutdown Causes Market Distortion

The global COVID-19 pandemic has been unprecedented and staggering, with transcatheter mitral valve repair and replacement (tmvr) industry experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 outbreak caused problems for manufacturers of healthcare materials, including unstable markets, a drop in customer confidence, and difficulties with import and export commerce. The sourcing of raw materials, packaging, and distribution are all parts of the global supply chain. Due to lockdowns, moving commodities, labels, and other items has become difficult. In addition to having an immediate influence on markets, supply chains, supply and demand, and all of these other things, it also had a financial impact on the markets for healthcare. The pandemic altered the dynamics of the industry, compelling organizations to redesign every aspect of their operational frameworks in order to preserve stability amidst the disturbances. Aside from that, the companies' business operations have been affected by the outbreak, which has an effect on the overall healthcare industry. This has partially impacted the transcatheter mitral valve repair and replacement (tmvr) industry.

LATEST TRENDS

Clinical Experience to Boost the Market Growth

Increased clinical experience in the field of Transcatheter Mitral Valve Repair and Replacement (TMVR) has had a significant impact on the market. Patient outcomes have usually improved as more hospitals and interventional cardiologists gain expertise in TMVR operations. Clinicians' improved methods have minimized problems and improved patient outcomes. Clinicians are increasingly open to considering a wider spectrum of patients as treatment candidates as they gain proficiency with TMVR procedures. The potential market size for TMVR has grown as a result of the growth in patient eligibility. Greater procedural efficiency has been achieved through clinical experience. Experienced teams can do TMVR operations more quickly and precisely, potentially lowering hospital stays and healthcare expenditures. Thus, a key trend that is opening up potential for the industry to grow is the increased clinical experience. These new developments are mostly to blame for the market's overall growth.

• According to the U.S. Food and Drug Administration (FDA), more than 85,000 transcatheter mitral valve procedures were performed globally in 2023, marking a 41% increase compared with 2020. This rapid adoption is supported by accelerated regulatory approvals for next-generation TMVR devices in over 30 countries, improving accessibility and reducing procedural risks.

• According to the European Society of Cardiology (ESC), over 28% of mitral regurgitation patients in Europe are now eligible for transcatheter-based interventions compared to only 10% in 2017. This shift reflects a growing preference for minimally invasive solutions, with procedural success rates exceeding 94% across specialized cardiac centers.

Download Free Sample to learn more about this report

TRANSCATHETER MITRAL VALVE REPAIR AND REPLACEMENT (TMVR) MARKET SEGMENTATION

By Type

Based on type, the market is classified into In Repair & Replacement.

By Application

Based on the market is categorized into Hospitals, Ambulatory Surgical Centers & Diagnostic Centers.

DRIVING FACTORS

Healthcare Cost Containment that Gives the Market Extra Boost

Healthcare cost containment plays a significant role in the Transcatheter Mitral Valve Repair and Replacement (TMVR) industry, influencing various aspects of this medical procedure. For patients who qualify, TMVR is frequently seen as a more affordable option than conventional open-heart surgery. Typically, it involves fewer critical care unit visits, shorter hospital stays, and quicker recovery times. For both individuals and healthcare systems, this may result in lower overall healthcare costs. Compared to open cardiac surgery, less invasive techniques like TMVR typically have lower rates of post-operative problems. Less complications mean lower healthcare costs for more prescriptions, prolonged hospital stays, and follow-up treatments. As a result, the growth, and the increased healthcare cost containment will boost the market. It will contribute to the expansion of the healthcare industry and it will improve the overall Transcatheter Mitral Valve Repair and Replacement (TMVR) Market growth.

Technological Advancement to Encourage Market Expansion

Advancements in technology have played a pivotal role in the evolution and growth of the Transcatheter Mitral Valve Repair and Replacement (TMVR) industry. These technical advancements have increased the TMVR procedures' accessibility, effectiveness, and safety. Continuous innovation has been demonstrated in TMVR equipment. Manufacturers have created more sophisticated and adaptable products, like implantable annuloplasty rings, transcatheter mitral valve replacement devices, and mitral valve repair clips (like the Mitra Clip). Advanced imaging methods have improved the ability to see the mitral valve and provide advice for TMVR procedures, including 3D transesophageal echocardiography (TEE) and intracardiac echocardiography (ICE). Real-time, high-resolution images provided by these technologies help with precise device installation. As a result, these factors are collectively promoting market expansion, increasing company revenues. As a result, above mentioned factors will help the market to boost.

• According to the World Health Organization (WHO), cardiovascular diseases remain the leading global cause of death, accounting for 17.9 million fatalities annually, with 2–3% linked to mitral valve dysfunctions. This high disease burden is driving hospitals and clinics to adopt TMVR solutions that reduce hospitalization time by 30–40% compared with open-heart surgery.

• According to the American Heart Association (AHA), patients undergoing TMVR have demonstrated a 52% reduction in hospital readmission rates for heart failure compared with those treated with traditional valve repair. The increased clinical success and shorter recovery times are encouraging healthcare systems in over 20 U.S. states to include TMVR under insurance reimbursements.

RESTRAINING FACTORS

Complex Patient Selection to Impede Market Expansion

Complex patient selection is the barrier to market expansion. It can be difficult to find the best candidates for TMVR. Not all people with mitral valve disease are candidates for the operation, and patient selection criteria are crucial. The use of TMVR may be restricted by complex anatomical changes and the severity of the condition. These limitations limit the market's overall growth. This may be a significant issue limiting market expansion. If this problem is fixed, the market will start to grow right away.

• According to the U.S. Centers for Medicare & Medicaid Services (CMS), the average cost of a TMVR procedure remains approximately 3.5 times higher than conventional surgical repair. This cost disparity limits accessibility in developing economies, where per capita healthcare expenditure averages below USD 1,500 per year, reducing patient adoption rates by nearly 18%.

• According to the National Institutes of Health (NIH), only 62% of healthcare facilities performing valve replacements globally possess the required imaging and catheterization infrastructure for TMVR. This lack of technological readiness, particularly in Asia-Pacific and Latin America, poses logistical and operational barriers to large-scale implementation.

• Download Free Sample to learn more about this report

•  

TRANSCATHETER MITRAL VALVE REPAIR AND REPLACEMENT (TMVR) MARKET REGIONAL INSIGHTS

North America Dominating the Market Across the Globe

The market for transcatheter mitral valve repair and replacement (tmvr) in North America has benefited from the region's expanding industrial development, and various driving factors which has increased the potential sectors as this region is the largest user of the product. The key factor driving the growth of the Transcatheter Mitral Valve Repair and Replacement (TMVR) Market share is the growing demand of products in hospitals, ambulatory surgical centers & diagnostic centers one of the major reasons to drive the market. Rapid urbanization developments will further boost the overall market.

KEY INDUSTRY PLAYERS

Leading Manufacturers to Boost Product Demand

Study includes information on the market players and where they stand within the sector. Data is being collected and made available through proper research, mergers, technical advancement, growing production facilities, and cooperation. The study on materials offers details on manufacturers, regions, types, applications, sales channels, distributors, traders, dealers, research findings, and more.

• Medtronic (Ireland/U.S.): According to the U.S. Department of Health and Human Services (HHS), Medtronic’s TMVR technologies have been utilized in over 40,000 clinical procedures worldwide as of 2024. The company has collaborated with 15 national cardiac institutes to develop imaging-guided catheter technologies that reduce procedural complications by 27%.

• Abbott Laboratories (U.S.): According to the American College of Cardiology (ACC), Abbott’s MitraClip and related TMVR systems have achieved a 97% procedural success rate across 1,200 medical centers globally. The company’s clinical training initiatives have reached over 5,000 cardiologists in partnership with national healthcare associations to enhance minimally invasive cardiac treatment skills.

List of Top Transcatheter Mitral Valve Repair And Replacement (Tmvr) Companies

• Medtronic (Ireland)
• Abbott Laboratories (U.S.)
• Edwards (U.S.)
• LivaNova (U.K.)

REPORT COVERAGE

The study goes into great detail about market segmentation by type and application. The study examines a broad range of participants, including existing and potential market leaders. A considerable market expansion is anticipated as a result of several important factors. In order to provide market insights, the research additionally analyses elements that are probably to boost Transcatheter Mitral Valve Repair and Replacement (TMVR) Market share. The report makes forecasts for market expansion during the projected time period. The objective of the regional study is to explain why one region dominates the worldwide market. There are a lot of issues that have all been carefully considered that prevent the industry from growing. The research also contains a market strategic analysis. It includes thorough market information.